StockData
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. (SCNX) stock

SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$2.76−0.23 (-7.69%)

Close on Nov 17, 2026Market cap $113.34MP/E –Yield –

Scienture price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Scienture's price to sales ratio was 402.1× on Jan 30, 2026, against 27.5× a year earlier. Over the last 5 years it ranged from 6.8× to 451.4×, with a median of 61.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 2026402.1×−49.3
2025Dec 31, 2025451.4×+352.5
2024Apr 30, 202498.9×+68.6
2023Dec 29, 202330.3×+22.6
2022Dec 30, 20227.7×−43.0
2021Dec 31, 202150.7×−12.7
2020Dec 31, 202063.4×−87.6
2019Dec 31, 2019151.0×+79.0
2018Dec 31, 201872.1×−55.3
2017Dec 29, 2017127.4×+18.2
2016Dec 30, 2016109.2×−100.9
2015Dec 31, 2015210.1×–

More Scienture figures

See a number that looks wrong?